These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33161447)

  • 1. Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma.
    Ha SY; Yeo SY; Lee KW; Kim SH
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):423-433. PubMed ID: 33161447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis.
    Aiyama T; Orimo T; Yokoo H; Ohata T; Hatanaka KC; Hatanaka Y; Fukai M; Kamiyama T; Taketomi A
    PLoS One; 2020; 15(9):e0239462. PubMed ID: 32956413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
    Choi S; Lee KW; Koh HH; Park S; Yeo SY; Joh JW; Choi MS; Kim SH; Park CK; Ha SY
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3517-3534. PubMed ID: 34462784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
    Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
    Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
    Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
    BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma.
    Jiang L; Zeng X; Yang H; Wang Z; Shen J; Bai J; Zhang Y; Gao F; Zhou M; Chen Q
    Int J Cancer; 2008 Oct; 123(8):1779-86. PubMed ID: 18688849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ruan J; Zheng H; Rong X; Rong X; Zhang J; Fang W; Zhao P; Luo R
    Mol Cancer; 2016 Feb; 15():17. PubMed ID: 26896959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinoma.
    Lv C; Li XJ; Hao LX; Zhang S; Song Z; Ji XD; Gong B
    Clin Transl Oncol; 2022 Jan; 24(1):93-103. PubMed ID: 34282556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
    Lee N; Kwon JH; Kim YB; Kim SH; Park SJ; Xu W; Jung HY; Kim KT; Wang HJ; Choi KY
    Oncotarget; 2015 Oct; 6(30):30130-48. PubMed ID: 26375549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival.
    Kato Y; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(2):155-163. PubMed ID: 28787731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma.
    Miura S; Mitsuhashi N; Shimizu H; Kimura F; Yoshidome H; Otsuka M; Kato A; Shida T; Okamura D; Miyazaki M
    BMC Cancer; 2012 Feb; 12():56. PubMed ID: 22309595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
    Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
    Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
    Feng J; Zhu R; Chang C; Yu L; Cao F; Zhu G; Chen F; Xia H; Lv F; Zhang S; Sun L
    PLoS One; 2016; 11(3):e0151501. PubMed ID: 26977595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
    Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
    Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma.
    Zhang HX; Jiang SS; Zhang XF; Zhou ZQ; Pan QZ; Chen CL; Zhao JJ; Tang Y; Xia JC; Weng DS
    Oncotarget; 2015 Oct; 6(33):34800-17. PubMed ID: 26430962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.